Anxiety is reportedly spreading at Nike as executives are telling employees to curb excess spending in the midst of disappointing earnings, which sent the storied company’s stock plummeting by 14% on ...
Incyte (NASDAQ:INCY) today announced appointments among its executive leadership team to support the Company’s strategic focus and long-term growth plans. Pablo J. Cagnoni, M.D., has been appointed ...
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (NASDAQ:INCY) today announced appointments among its executive leadership team to support the Company’s strategic focus and long-term growth plans. Except ...
Nike beat Wall Street's earnings and revenue estimates for its third fiscal quarter, but it gave a weaker-than-expected sales outlook for its current quarter. Revenue in its struggling Greater China ...
Nike CEO says its comeback plan is taking longer than expected, sending shares tumbling more than 8%
Nike's Q3 2026 revenue stayed flat at $11.3 billion, and shares dropped over 8% after market close. Running led Nike's growth, highlighting the focus on performance wear. Nike's digital sales fell due ...
March 28 (Reuters) - Incyte (INCY.O), opens new tab said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in two late-stage trials. The company tested the drug, ...
Nike’s soon-to-be-reissued Sprint Sister model isn’t the only sneaker in the brand’s archive that’s getting a double-laced makeover exclusively for women. Also in line for the whimsical makeover is ...
Nike reported flat revenue and another decline in profits. The company said it would return to gross margin growth in three quarters. Tariffs are weighing on profits and it's still cutting inventory.
Nike reported third quarter results on Tuesday that beat estimates despite continued weakness in its China business and steep declines at Converse. Net income at the Beaverton, Ore.-based company in ...
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through ...
Nike may have beat Wall Street's fiscal 2026 third-quarter earnings expectations but it wasn't enough to win over investors losing patience with CEO Elliott Hill's turnaround. The sneaker giant ...
Nike is attempting to turn things around, but it could be a long road to success. The athletic company closed out March with the release of its latest earnings. The fiscal 2026 third-quarter report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results